Comparative Performance of PureVision, Acuvue Oasys and O2Optix

NCT ID: NCT00640341

Last Updated: 2011-12-12

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

510 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-02-29

Study Completion Date

2008-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to evaluate the performance of the PureVision Contact Lens compared to Acuvue Oasys Contact lens and O2Optix Contact lens when worn on a daily wear basis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PureVision

PureVision Contact Lens

Group Type EXPERIMENTAL

PureVision Contact Lens

Intervention Type DEVICE

contact lens for daily wear

Acuvue Oasys

Acuvue Oasys Contact Lens

Group Type ACTIVE_COMPARATOR

Acuvue Oasys Contact Lens

Intervention Type DEVICE

contact lens for daily wear

O2Optix

O2Optix Contact Lens

Group Type ACTIVE_COMPARATOR

O2Optix Contact lens

Intervention Type DEVICE

contact lens for daily wear

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PureVision Contact Lens

contact lens for daily wear

Intervention Type DEVICE

Acuvue Oasys Contact Lens

contact lens for daily wear

Intervention Type DEVICE

O2Optix Contact lens

contact lens for daily wear

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is myopic
* VA correctable to 0.3 LogMAR or better (driving vision)
* Clear central cornea
* Subject uses a lens care system on a regular basis

Exclusion Criteria

* Systemic disease affecting ocular health
* Using systemic or topical medications
* Wear monovision, multifocal or toric contact lenses
* Any grade 2 or greater slit lamp findings
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bausch & Lomb Incorporated

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gerard Cairns, MCOptom, PhD

Role: STUDY_DIRECTOR

Bausch & Lomb Incorporated

Bruce Anderson, OD

Role: PRINCIPAL_INVESTIGATOR

Anderson & Associates

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Anderson & Associates

Tampa, Florida, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

552

Identifier Type: -

Identifier Source: org_study_id